Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,064 | 0,087 | 15.05. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.04. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Gall to business advisory board | 1 | Stockwatch | ||
30.04. | Ventripoint Diagnostics Ltd.: Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive | 1 | TheNewswire | ||
11.04. | Ventripoint Diagnostics Ltd (2): Ventripoint to hold shareholder teleconference April 15 | 1 | Stockwatch | ||
10.04. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Teleconference | 1 | TheNewswire | ||
VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint $500,000 debenture private placement | 1 | Stockwatch | ||
08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Coutin to oversee clinical affairs | 2 | Stockwatch | ||
08.04. | Ventripoint Diagnostics Ltd.: Ventripoint Appoints Nicolas Coutin to Oversee Clinical Affairs | - | TheNewswire | ||
08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics warrants extended | 1 | Stockwatch | ||
04.04. | Ventripoint Diagnostics Ltd (2): Ventripoint applies to extend 2.84 million warrants | 1 | Stockwatch | ||
03.04. | Ventripoint Diagnostics Ltd.: Ventripoint Makes Application to Amend Warrants | 1 | TheNewswire | ||
24.03. | Ventripoint Diagnostics Ltd (2): Ventripoint publishes white paper on AI use | 1 | Stockwatch | ||
24.03. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Publishes Whitepaper on the Use of AI in Whole-Heart Analysis | 4 | TheNewswire | ||
22.03. | Ventripoint Diagnostics Ltd (2): Ventripoint 5.97-million-share private placement | 3 | Stockwatch | ||
21.03. | Ventripoint Diagnostics Ltd (2): Ventripoint closes $500,000 private placement | 1 | Stockwatch | ||
21.03. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of $500,000 Non-Brokered Convertible Debenture Unit Private Placement | 4 | TheNewswire | ||
14.03. | Ventripoint Diagnostics Ltd (2): Ventripoint arranges $500,000 private placement | 4 | Stockwatch | ||
14.03. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement | 2 | TheNewswire | ||
06.03. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 83,864 shares for debt | 3 | Stockwatch | ||
28.02. | Ventripoint Diagnostics Ltd (2): Ventripoint receives FDA clearance for VMS+ 4.0 system | 3 | Stockwatch | ||
27.02. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+ 4.0 Automated Radiological Image Processing Software/System | 4 | TheNewswire |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
TANDEM DIABETES | 20,320 | +0,10 % | Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set | ||
VERU | 0,450 | -1,19 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
MOLINA HEALTHCARE | 268,80 | -4,24 % | Aktienmarkt: Aktie von Molina Healthcare tritt auf der Stelle (270,6171 €) | An der US-amerikanischen Börse ist die Molina Healthcare-Aktie aktuell unauffällig. Zuletzt zahlten Investoren für das Wertpapier 307,90 US-Dollar. Wenig getan hat sich heute bislang beim Kurs von Molina... ► Artikel lesen | |
CLOVER HEALTH INVESTMENTS | 2,880 | -5,70 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
SOMNIGROUP INTERNATIONAL | 58,50 | -0,85 % | Here's Why Somnigroup International (SGI) Rose in Q1 | ||
SHL TELEMEDICINE | - | - | SHL TELEMEDICINE LTD - 20-F, Annual and transition report of foreign private issuers | ||
SINTX TECHNOLOGIES | 3,255 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization | Salt Lake City, UT, May 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT), an advanced ceramics company pioneering medical and antipathogenic applications of silicon nitride (Si3N4)... ► Artikel lesen | |
SMILEDIRECTCLUB | - | - | Are you a former SmileDirectClub customer? You might be eligible for a refund | ||
SEMLER SCIENTIFIC | 28,000 | -1,41 % | Semler Scientific, Inc.: Semler Scientific Reports First Quarter 2025 Financial Results, BTC Yield of 22.2% YTD; Now holds 3,808 BTC | CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted bitcoin as its primary treasury... ► Artikel lesen | |
NEURONETICS | 3,710 | -3,51 % | Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month | ||
RELEVIUM | 0,013 | -100,00 % | Relevium Technologies Inc.: Relevium Technologies to be delisted from NEX | ||
FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
UNITEDHEALTH | 245,05 | -0,04 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 48,850 | +1,45 % | EQS-DD: Siemens Healthineers AG: Astrid Kristine Ploß, Anspruch auf Übertragung von 73 Siemens Healthineers Aktien im Zusammenhang mit einem Siemens Healthineers Aktienprogramm (Übertragung ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
09.05.2025 / 14:49... ► Artikel lesen |